Benitec Biopharma Inc. (BNTC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Benitec Biopharma Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -11.17x | -3.43x | -0.29x | -2.08x | -5.26x | -3.91x |
| P/B Ratio | 4.35x | 1.58x | 27.85x | 13.16x | 3.65x | 3.16x |
| P/S Ratio | 0.00x | 0.00x | 75.02x | 519.41x | 1237.66x | 333.10x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | -408.0% | 87.7% | -108.5% | 290.7% |
| Operating Margin | 0.0% | 0.0% | -25441.3% | -24457.5% | -23044.1% | -8537.1% |
| Net Margin | 0.0% | 0.0% | -26082.7% | -24942.5% | -23528.8% | -8529.9% |
| EBITDA Margin | 0.0% | 0.0% | -25530.7% | -24457.5% | -22800.0% | -8151.5% |
| Liquidity | ||||||
| Current Ratio | 54.67x | 10.49x | 0.94x | 1.90x | 15.05x | 9.51x |
| Quick Ratio | 54.67x | 10.49x | 0.94x | 1.90x | 15.05x | 9.51x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.01x | 2.77x | 0.28x | 0.01x | 0.04x |
YoY = year-over-year change. Source: FMP..